Long-term outcome of surgical excision for treatment of cervicofacial granulomatous lymphadenitis in children

Eur Arch Otorhinolaryngol. 2020 Jun;277(6):1785-1792. doi: 10.1007/s00405-020-05880-5. Epub 2020 Mar 6.

Abstract

Purpose: Granulomatous inflammation is a common cause of subacute cervicofacial lymphadenitis in children. Nontuberculous mycobacterial (NTM) infections and cat-scratch disease (CSD) are the most frequent causes. Optimal treatment, which may include surgery, antibiotic treatment or wait-and-see approach, is debatable. The goal of this study was to compare the short- and long-term outcome of various surgical procedures.

Methods: Case series with a chart review of all children treated by surgical excision of granulomatous lymph nodes in the cervicofacial area from 2000 to 2016 at two tertiary care centers.

Results: Forty patients were included in this study. The median age at first symptoms was 3.7 years (13 months-14 years). Mean follow-up was 5.8 years (6 months-15.3 years). 25 patients fit with diagnosis of NTM infection, 6 with CSD while diagnosis remained uncertain in 9 patients. The primary surgical procedure consisted of total excision (n = 27), incision/drainage (n = 9) or incomplete excision (n = 4). None of the patients treated by primary complete excision needed further intervention contrary to the group of patients with incomplete surgical procedures where additional surgical management was required in 54%. At follow-up, all patients were healthy without evidence of recurrence.

Conclusion: We advocate early surgical intervention with complete excision to reach quick resolution and reduce the need for additional surgery. The long-term outcome was favorable.

Keywords: Cat-scratch disease; Children; Lymphadenitis; Nontuberculous mycobacteria; Surgery.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Humans
  • Infant
  • Lymph Node Excision
  • Lymph Nodes / surgery
  • Lymphadenitis* / surgery
  • Mycobacterium Infections, Nontuberculous*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents